NHC Comments on Request for Information (RFI) on the future of 21st Century Cures 2.0 legislation (PDF) August 2, 2024 The Honorable Diana DeGette […]
Letters + Comments
NHC Comments on National Institutes of Health (NIH) Office of Science Policy (OSP): Request for Information on Draft NIH Intramural Research Program Policy: Promoting Equity Through Access Planning
NHC Comments on National Institutes of Health (NIH) Office of Science Policy (OSP): Request for Information on Draft NIH Intramural Research Program Policy: Promoting Equity Through Access Planning (PDF) July […]
NHC Comments on the Federal Evidence Agenda on Disability Equity
NHC Comments on the Federal Evidence Agenda on Disability Equity (PDF) July 15, 2024 Office of Science and Technology Executive Office of the President 1650 Pennsylvania Avenue NW Washington, DC […]
NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027
NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation […]
NHC Comments on Medicare Advantage and Prescription Drug Programs: Part C and Part D Medicare Prescription Payment Plan Model Documents (CMS-10882) – IRA
NHC Comments on Medicare Advantage and Prescription Drug Programs: Part C and Part D Medicare Prescription Payment Plan Model Documents (CMS-10882) – IRA (PDF) June 27, 2024 Chiquita Brooks-LaSure Administrator […]
NHC Comments on Response to the Medicare Program; Request for Information on Medicare Advantage Data
NHC Comments on Response to the Medicare Program; Request for Information on Medicare Advantage Data (PDF) May 29, 2024 Chiquita Brooks-LaSure Administrator Centers for Medicare & Medicaid Services Department of […]
NHC Comments on Key Information and Facilitating Understanding in Informed Consent
NHC Comments on Key Information and Facilitating Understanding in Informed Consent (PDF) April 30, 2024 Division of Dockets Management Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD […]
NHC Comments on Medicare Advantage and Prescription Drug Programs: Part C and Part D Medicare Prescription Payment Plan Model Documents
NHC Comments on Medicare Advantage and Prescription Drug Programs: Part C and Part D Medicare Prescription Payment Plan Model Documents (PDF) April 29, 2024 Chiquita Brooks-LaSure Administrator Centers for Medicare […]
NHC Statement for House Energy and Commerce Hearing
NHC Statement for House Energy and Commerce Hearing (PDF) April 10, 2024 The Honorable Brett Guthrie Chair Committee on Energy and Commerce United States House of Representatives Washington, DC 20515 […]
NHC Statement on House Ways and Means Telehealth Hearing
NHC Statement on House Ways and Means Telehealth Hearing (PDF) March 22, 2024 The Honorable Jason Smith Chair Committee on Ways and Means United States House of Representatives Washington, DC […]